Caprock Group, Inc. Catalent, Inc. Transaction History

Caprock Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	BUY	$87.2 - $114.05 $163,412 - $213,729	1,874 New	1,874 $201,000
Q1 2022 Apr 12, 2022	SELL	$94.19 - $124.49 $273,151 - $361,021	-2,900 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$119.57 - $139.07 $71,024 - $82,607	594 Added 25.76%	2,900 $371,000
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $25,988 - $29,963	259 Added 12.65%	2,306 $249,000
Q1 2021 Apr 29, 2021	BUY	$101.51 - $125.27 $207,790 - $256,427	2,047 New	2,047 $216,000
Q2 2018 Jul 23, 2018	SELL	$38.72 - $42.52 $227,673 - $250,017	-5,880 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$39.4 - $47.39 $45,704 - $54,972	1,160 Added 24.58%	5,880 $241,000
Q4 2017 Jan 17, 2018	BUY	$37.27 - $43.02 $175,914 - $203,054	4,720	4,720 $203,000

118

37.8M

123K

432K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.